22 October[removed]Christine Chapman Therapeutic Group Manager PHARMAC PO Box[removed]

First Page		Document Content
Date: 2013-11-07 15:04:11 Respiratory therapy Leukotriene antagonists Cyclopropanes Merck Montelukast Pharmaceutical Management Agency Exercise-induced asthma Asthma NZMA Pulmonology Medicine Healthcare in New Zealand		22 October[removed]Christine Chapman Therapeutic Group Manager PHARMAC PO Box[removed] Add to Reading List Source URL: www.nzma.org.nz Download Document from Source Website File Size: 172,85 KB Share Document on Facebook

	Communication pubs.acs.org/JACS Highly Diastereo- and Enantioselective Synthesis of TriﬂuoromethylSubstituted Cyclopropanes via Myoglobin-Catalyzed Transfer of Triﬂuoromethylcarbene Antonio Tinoco, Viktoria Steck, Vi DocID: 1uSIY - View Document
	New Drugs Approved in FY 2015 Review Category Approval Date No. DocID: 1r3Vv - View Document
	Microsoft Word - GILEAD BRIEFING DocID: 1r2Vm - View Document
	Treatment of Chronic Hepatitis C - January 2016 Update (The changes compared to the November 2015 Update are highlighted in yellow) Swiss Association for the Study of the Liver and Swiss Society for Infectious Diseases DocID: 1qOAQ - View Document
	Personalized Medicine Using genetic information to Help Fight Disease Personalized medicine is changing the way patients with Hepatitis C are treated…and cured.1 What is Personalized Medicine? DocID: 1qCC6 - View Document